#48 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
Nebraska patients who voted for medical cannabis access may find that the available products and eligible physicians are significantly limited under these new rules, potentially forcing some to go without care or seek alternatives outside the legal system.
Nebraska’s newly implemented medical cannabis regulations have introduced restrictions on which parts of the cannabis plant can be used, placed caps on THC concentration, and created new licensure requirements for physicians who recommend the drug. These rules reflect a cautious regulatory framework that prioritizes gatekeeping over patient access, which is a common tension seen when states build medical cannabis programs from scratch. Patients and advocates argue that such restrictions limit therapeutic options, particularly for those whose conditions may respond better to higher-potency or whole-plant formulations.
“Writing THC limits into statute rather than clinical guidelines is like capping the maximum dose of a medication before anyone has been allowed to prescribe it.”
Nebraska’s new medical cannabis regulations highlight the ongoing tension between evidence-based clinical practice and restrictive policy frameworks. Physician-led restrictions on plant parts and arbitrary THC limits can inadvertently limit treatment options for patients who might benefit from whole-plant or higher-cannabinoid formulations based on individual clinical need. Overly burdensome licensing requirements for prescribing physicians may create barriers to care, particularly in rural areas where access to cannabis-knowledgeable providers is already limited. As more states establish medical programs, regulations should prioritize clinical flexibility and physician autonomy while maintaining appropriate patient safety oversight.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: